Research & Teaching Faculty

Default Header Image

Regulation of mitosis and taxane response by Daxx and Rassf1

TitleRegulation of mitosis and taxane response by Daxx and Rassf1
Publication TypeJournal Article
Year of Publication2012
AuthorsGiovinazzi, S, Lindsay, CR, Morozov, VM, Escobar-Cabrera, E, Summers, MK, Han, HS, McIntosh, LP, Ishov, AM
JournalONCOGENE
Volume31
Pagination13-26
Date PublishedJAN
ISSN0950-9232
Abstract

Current theories suggest that mitotic checkpoint proteins are essential for proper cellular response to taxanes, a widely used family of chemotherapeutic compounds. We recently showed that absence or depletion of protein Daxx increases cellular taxol (paclitaxel) resistance-a common trait of patients diagnosed with several malignancies, including breast cancer. Further investigation of Daxx-mediated taxol response revealed that Daxx is important for the proper timing of mitosis progression and cyclin B stability. Daxx interacts with mitotic checkpoint protein RAS-association domain family protein 1 (Rassf1) and partially colocalizes with this protein during mitosis. Rassf1/Daxx depletion or expression of Daxx-binding domain of Rassf1 elevates cyclin B stability and increases taxol resistance in cells and mouse xenograft models. In breast cancer patients, we observed the inverse correlation between Daxx and clinical response to taxane-based chemotherapy. These data suggest that Daxx and Rassf1 define a mitotic stress checkpoint that enables cells to exit mitosis as micronucleated cells (and eventually die) when encountered with specific mitotic stress stimuli, including taxol. Surprisingly, depletion of Daxx or Rassf1 does not change the activity of E3 ubiquitin ligase anaphase promotion complex/C in in vitro settings, suggesting the necessity of mitotic cellular environment for proper activation of this checkpoint. Daxx and Rassf1 may become useful predictive markers for the proper selection of patients for taxane chemotherapy. Oncogene (2012) 31, 13-26; doi: 10.1038/onc.2011.211; published online 6 June 2011

DOI10.1038/onc.2011.211